Literature DB >> 3229918

Anterior transposition of the third part of the duodenum in the management of chronic duodenal compression by the superior mesenteric artery.

S O Duvie1.   

Abstract

Transposition of the third part of the duodenum anteriorly to the superior mesenteric vessels was performed in ten patients with chronic duodenal obstruction due to compression by the superior mesenteric artery (SMAS). Follow-up evaluation showed that all the patients (a) had complete relief of their preoperative symptoms, (b) could tolerate normal diet postoperatively and (c) gained weight rapidly following surgery. There were no major complications or deaths among the patients so treated. The Author feels that this technique is more direct approach, aimed at permanently circumventing the obstruction for these groups of patients selected on the basis of the radiological, pathological and operative findings. The success encountered with the patients so treated would seem to confirm this impression.

Entities:  

Mesh:

Year:  1988        PMID: 3229918

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  4 in total

1.  Superior mesenteric artery syndrome in a patient with Charcot Marie Tooth disease.

Authors:  Oscar Dario Gómez Beltrán; Amparo Valverde Martínez; María Del Carmen Pérez Manrique; Joaquín Sánchez Rodríguez; Enrique Lizárraga Febres; Sebastián Rufián Peña
Journal:  World J Gastrointest Surg       Date:  2011-12-27

2.  Superior mesenteric artery syndrome: a single centre experience of laparoscopic duodenojejunostomy as the operation of choice.

Authors:  G C Kirby; E R Faulconer; S J Robinson; A Perry; R Downing
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

Review 3.  Superior mesenteric artery syndrome.

Authors:  A R Ahmed; I Taylor
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

4.  Laparoscopic duodenojejunostomy for superior mesenteric artery syndrome.

Authors:  Reyaz M Singaporewalla; Davide Lomato; Thiow K Ti
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.